CORC

在结果中检索

CORC

浏览/检索结果: 共90条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文
LIVER CANCER, 2022, 卷号: 11
作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2021
作者:  Lin, Yansong;  Qin, Shukui;  Li, Zhiyong;  Yang, Hui;  Fu, Wei
收藏  |  浏览/下载：59/0  |  提交时间：2022/01/25
Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：20/0  |  提交时间：2022/01/10
Highly Sensitive InSb Nanosheets Infrared Photodetector Passivated by Ferroelectric Polymer 期刊论文
ADVANCED FUNCTIONAL MATERIALS, 2020, 卷号: 30, 期号: 51, 页码: 2006156
作者:  Shukui Zhang;   Hanxue Jiao;   Xudong Wang;   Yan Chen;   Hailu Wang;   Liqing Zhu;  Wei Jiang;   Jingjing Liu;   Liaoxin Sun;   Tie Lin;   Hong Shen;   Weida Hu;   Xiangjian Meng;  Dong Pan;   Jianlu Wang;   Jianhua Zhao;   Junhao Chu
收藏  |  浏览/下载：42/0  |  提交时间：2021/05/24
Comparison of urban growth patterns and changes between three urban agglomerations in China and three metropolises in the USA from 1995 to 2015 期刊论文
SUSTAINABLE CITIES AND SOCIETY, 2019, 卷号: 50, 页码: 11
作者:  He, Qingsong;  Zeng, Chen;  Xie, Peng;  Tan, Shukui;  Wu, Jiayu
收藏  |  浏览/下载：8/0  |  提交时间：2020/03/23
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：113/0  |  提交时间：2019/12/05
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130, 页码: 18-24
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：28/0  |  提交时间：2019/11/19
Comparison of urban growth patterns and changes between three urban agglomerations in China and three metropolises in the USA from 1995 to 2015 期刊论文
Sustainable Cities and Society, 2019, 卷号: 50
作者:  He, Qingsong;  Zeng, Chen;  Xie, Peng;  Tan, Shukui;  Wu, Jiayu
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace